Gain Therapeutics, Inc. — All Filings
217 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| EFFECT | — | 9999999995-22-001659 | Jun 1, 2022 | — |
| CORRESP | — | 0001104659-22-066685 | May 31, 2022 | — |
| 4 | — | 0001415889-22-005798 | May 27, 2022 | May 25, 2022 |
| 4 | — | 0001415889-22-005501 | May 23, 2022 | May 19, 2022 |
| S-3/A | S-3/A | 0001104659-22-063887 | May 23, 2022 | — |
| 4/A | — | 0001415889-22-005491 | May 23, 2022 | May 19, 2022 |
| UPLOAD | — | 0000000000-22-005611 | May 20, 2022 | — |
| 4 | — | 0001415889-22-005317 | May 19, 2022 | — |
| S-3 | S-3 | 0001104659-22-062504 | May 18, 2022 | — |
| 10-Q | 10-Q | 0001558370-22-008968 | May 16, 2022 | Mar 31, 2022 |
| 8-K | 8-K | 0001558370-22-008959 | May 16, 2022 | — |
| DEF 14A | DEF 14A | 0001104659-22-060288 | May 13, 2022 | Jun 16, 2022 |
| 10-K/A | FORM 10-K/A | 0001104659-22-054769 | May 2, 2022 | Dec 31, 2021 |
| 4/A | FORM 4/A SUBMISSION | 0001209191-22-025180 | Apr 21, 2022 | Aug 16, 2021 |
| 3/A | FORM 3/A SUBMISSION | 0001209191-22-025179 | Apr 21, 2022 | Mar 17, 2021 |
| 10-K | 10-K | 0001558370-22-004363 | Mar 25, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0001558370-22-004214 | Mar 24, 2022 | — |
| 4 | — | 0001415889-21-006258 | Dec 28, 2021 | Dec 23, 2021 |
| 3 | — | 0001415889-21-006255 | Dec 28, 2021 | Dec 23, 2021 |
| 8-K | 8-K | 0001558370-21-017044 | Dec 28, 2021 | Dec 23, 2021 |
| 10-Q | 10-Q | 0001558370-21-015636 | Nov 12, 2021 | Sep 30, 2021 |
| 8-K | 8-K | 0001558370-21-015627 | Nov 12, 2021 | — |
| 8-K | 8-K | 0001558370-21-013308 | Oct 20, 2021 | Oct 15, 2021 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-21-107121 | Aug 17, 2021 | Aug 16, 2021 |
| 10-Q | 10-Q | 0001558370-21-011445 | Aug 12, 2021 | Jun 30, 2021 |
| 8-K | 8-K | 0001558370-21-011278 | Aug 11, 2021 | — |
| 10-Q | 10-Q | 0001558370-21-006665 | May 10, 2021 | Mar 31, 2021 |
| 8-K | 8-K | 0001558370-21-006657 | May 10, 2021 | — |
| 8-K | 8-K | 0001558370-21-005685 | May 4, 2021 | May 3, 2021 |
| S-8 | FORM S-8 | 0001140361-21-011803 | Apr 6, 2021 | — |
| 3 | FORM 3 | 0001140361-21-010631 | Mar 29, 2021 | Mar 17, 2021 |
| 3 | FORM 3 | 0001140361-21-010628 | Mar 29, 2021 | Mar 17, 2021 |
| 3 | FORM 3 | 0001140361-21-010620 | Mar 29, 2021 | Mar 17, 2021 |
| 3 | FORM 3 | 0001140361-21-010618 | Mar 29, 2021 | Mar 17, 2021 |
| SC 13G/A | TITCOMB 13G - GAIN THERAPEUTICS, INC. | 0001786406-21-000002 | Mar 29, 2021 | — |
| 8-K | FORM 8-K | 0001140361-21-009490 | Mar 22, 2021 | Mar 17, 2021 |
| 424B4 | 424B4 | 0001140361-21-009381 | Mar 22, 2021 | — |
| EFFECT | — | 9999999995-21-000974 | Mar 17, 2021 | — |
| 3 | FORM 3 | 0001140361-21-008965 | Mar 17, 2021 | — |
| 3 | FORM 3 | 0001140361-21-008963 | Mar 17, 2021 | — |
| 3 | FORM 3 | 0001140361-21-008960 | Mar 17, 2021 | — |
| 3 | FORM 3 | 0001140361-21-008957 | Mar 17, 2021 | — |
| 3 | FORM 3 | 0001140361-21-008954 | Mar 17, 2021 | — |
| CERT | — | 0001354457-21-000360 | Mar 17, 2021 | — |
| 8-A12B | FORM 8-A12B | 0001140361-21-008904 | Mar 17, 2021 | — |
| CORRESP | — | 0001140361-21-008686 | Mar 16, 2021 | — |
| UPLOAD | — | 0000000000-21-003126 | Mar 16, 2021 | — |
| CORRESP | — | 0001140361-21-008516 | Mar 15, 2021 | — |
| CORRESP | — | 0001140361-21-008510 | Mar 15, 2021 | — |
| CORRESP | — | 0001140361-21-008505 | Mar 15, 2021 | — |